B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Stx64

2 PubMed studies analyzed · Evidence Score: 9.1

Research Domains

Stx64 has been studied across 2 research domains including 🔬 Oncology, 🧬 Hormones. The primary research focus is 🔬 Oncology with 50% of studies addressing this area.

Loading evidence profile...

This evidence profile for Stx64 is generated deterministically from 2 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.